Early Growth Response 3 (EGR3) (Middle Region) Peptide
EGR3
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all EGR3 products
- EGR3 (Early Growth Response 3 (EGR3))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-EGR3 antibody (Catalog #: ARP38463_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- EGR3 (Early Growth Response 3 (EGR3))
- Synonyms
- EGR-3 Peptide, PILOT Peptide, Pilot Peptide, zgc:92020 Peptide, early growth response 3 Peptide, early growth response protein 3 Peptide, EGR3 Peptide, Egr3 Peptide, egr3 Peptide, EGR-3 Peptide
- Background
-
EGR3 is a probable transcription factor involved in muscle spindle development.
Alias Symbols: MGC138484, PILOT, EGR-3
Protein Interaction Partner: FASLG
Protein Size: 387 - Molecular Weight
- 42 kDa
- Gene ID
- 1960
- NCBI Accession
- NM_004430, NP_004421
- UniProt
- Q06889
-
You are here:
